Irinotecan (hydrochloride) (Standard), CAS 100286-90-6

Product Description: Irinotecan (hydrochloride) (Standard) is the analytical standard of Irinotecan (hydrochloride). This product is intended for research and analytical applications. Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer[1].

Formula: C33H39ClN4O6

References: [1]Morales C, et al. Antitumoral effect of irinotecan (CPT-11) on an experimental model of malignant neuroectodermal tumor. J Neurooncol. 2002 Feb;56(3):219-26./[2]Pavillard V, et al. Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines. Cancer Chemother Pharmacol. 2002 Apr;49(4):329-35. Epub 2002 Jan 30./[3]Allegrini G, et al. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Cancer Chemother Pharmacol. 2004 Mar;53(3):261-6. Epub 2003 Dec 5.

CAS Number: 100286-90-6

Molecular Weight: 623.14

Research Area: Cancer

Target: Autophagy;Reference Standards;Topoisomerase

• SKU: MEXHY-16562AR-100
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-16562AR-100
• Package Unit: 100 mg
• Quantity Unit: STK